SENSEONICS HOLDINGS INC (SENS)
US81727U1051 - Common Stock
SENS gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 195 industry peers in the Health Care Equipment & Supplies industry. While SENS seems to be doing ok healthwise, there are quite some concerns on its profitability. SENS is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
SENS had negative earnings in the past year.
In the past year SENS has reported a negative cash flow from operations.
SENS had negative earnings in 4 of the past 5 years.
In the past 5 years SENS always reported negative operating cash flow.
1.2 Ratios
With a Return On Assets value of -43.69%, SENS is not doing good in the industry: 63.08% of the companies in the same industry are doing better.
SENS has a Return On Equity of -82.22%. This is in the lower half of the industry: SENS underperforms 62.56% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -43.69% | ||
| ROE | -82.22% | ||
| ROIC | N/A |
ROA(3y)-38.59%
ROA(5y)-138.09%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 13.81%, SENS is doing worse than 81.54% of the companies in the same industry.
The Profit Margin and Operating Margin are not available for SENS so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 13.81% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
SENS does not have a ROIC to compare to the WACC, probably because it is not profitable.
SENS has more shares outstanding than it did 1 year ago.
The number of shares outstanding for SENS has been increased compared to 5 years ago.
The debt/assets ratio for SENS has been reduced compared to a year ago.
2.2 Solvency
SENS has an Altman-Z score of -7.41. This is a bad value and indicates that SENS is not financially healthy and even has some risk of bankruptcy.
SENS has a Altman-Z score of -7.41. This is in the lower half of the industry: SENS underperforms 72.31% of its industry peers.
A Debt/Equity ratio of 0.56 indicates that SENS is somewhat dependend on debt financing.
SENS's Debt to Equity ratio of 0.56 is on the low side compared to the rest of the industry. SENS is outperformed by 67.69% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.56 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -7.41 |
ROIC/WACCN/A
WACC9.94%
2.3 Liquidity
SENS has a Current Ratio of 7.53. This indicates that SENS is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 7.53, SENS belongs to the best of the industry, outperforming 83.59% of the companies in the same industry.
SENS has a Quick Ratio of 7.03. This indicates that SENS is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 7.03, SENS belongs to the top of the industry, outperforming 85.64% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 7.53 | ||
| Quick Ratio | 7.03 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 11.76% over the past year.
SENS shows a strong growth in Revenue. In the last year, the Revenue has grown by 36.62%.
The Revenue has been growing slightly by 3.43% on average over the past years.
EPS 1Y (TTM)11.76%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-250%
Revenue 1Y (TTM)36.62%
Revenue growth 3Y65.39%
Revenue growth 5Y3.43%
Revenue growth Q2Q44.14%
3.2 Future
SENS is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.77% yearly.
Based on estimates for the next years, SENS will show a very strong growth in Revenue. The Revenue will grow by 34.50% on average per year.
EPS Next Y13.86%
EPS Next 2Y8.08%
EPS Next 3Y4.77%
EPS Next 5YN/A
Revenue Next Year19.13%
Revenue Next 2Y36.04%
Revenue Next 3Y34.5%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for SENS. In the last year negative earnings were reported.
Also next year SENS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y8.08%
EPS Next 3Y4.77%
5. Dividend
5.1 Amount
No dividends for SENS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
SENSEONICS HOLDINGS INC
NYSEARCA:SENS (4/26/2024, 7:15:40 PM)
After market: 0.4228 +0.01 (+1.71%)0.4157
0 (-0.6%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap220.60M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -43.69% | ||
| ROE | -82.22% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 13.81% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.16
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.56 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 7.53 | ||
| Quick Ratio | 7.03 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)11.76%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y13.86%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)36.62%
Revenue growth 3Y65.39%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y